Viewing nowLinawon 5 mg (Linagliptin)
Linagliptin 5mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

MFDS item code 201801878 · Approved 2018.05.02 · Insurance code 657808130
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps patients with type 2 diabetes to implement dietary and exercise therapies and is used as an adjunct to effectively improve blood sugar control. It can be used alone or in combination with other medications to enhance therapeutic effects. This medication plays an important role in blood sugar management, helping to improve the health of patients.
The recommended dose of this medicine is 5 mg once daily. It may be administered with or without food. When administered in combination with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin or the insulin secretagogue may be necessary to minimize the risk of hypoglycemia.
This medication should not be used in patients who have allergic reactions to the active ingredients or other components of this medication. It is safe not to administer to patients with type 1 diabetes or diabetic ketoacidosis. Caution is required when used with other medications that can cause hypoglycemia. In particular, the risk of hypoglycemia may increase when combined with insulin or sulfonylureas, so dosage adjustments may be necessary. Experience in administering this medication to heart failure patients is limited, so it should be used with caution. Signs of acute pancreatitis may occur, so if symptoms like abdominal pain persist, consult a doctor immediately, and discontinuation of this medication may be needed. A skin condition known as bullous pemphigoid may occur, so if blisters or irritation appear on the skin, inform a physician immediately. While using this medication, there may be adverse reactions such as hypoglycemia, gastrointestinal disturbances, skin rash, and joint pain, so consult healthcare professionals if symptoms arise. Its safety has not been established in pregnant or breastfeeding individuals, so its use should be avoided. Safety and efficacy have not been sufficiently verified in children and adolescents, so it is not recommended. Elderly individuals can use the medication without special dosage adjustments, but their condition should be monitored closely. Patients with impaired kidney or liver functions can also be administered without special dosage adjustments, but should be observed carefully. In case of overdose, unabsorbed medication should be removed from the gastrointestinal tract and symptoms should be observed, receiving necessary treatment. This medication should be stored out of reach of children and should not be transferred to other containers.
Hypoglycemia, hypertriglyceridemia, hyperlipidemia, nasopharyngitis, hypersensitivity, angioedema, urticaria, cough, pancreatitis, constipation, oral ulcer formation, rash, vesicular pemphigoid, severe and disabling arthralgia, rhabdomyolysis, weight gain, increased lipase, increased amylase, dyspepsia, edema, facial edema, peripheral edema, weight loss, increased appetite, constipation, abdominal pain, enterocolitis, intestinal obstruction, gastritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuritis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disorder, Alzheimer's dementia, chest pain, fever, facial swelling, fatigue, death, fatigue, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina pectoris, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, anemia, nausea, diarrhea, vomiting, gastroesophageal reflux disease, gastritis, viral upper respiratory infection, upper respiratory infection, gastroenteritis, dizziness, sensory loss, chest discomfort, asthenia, nosebleed, oropharyngeal pain, voice disorder, allergic rhinitis, exertional dyspnea, wet cough, rhinorrhea, pulmonary mass, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in blood, increased urine albumin/creatinine ratio, positive urine leukocytes, decreased hemoglobin, increased potassium in blood, increased creatinine in blood, increased creatine phosphokinase activity in blood, increased ALT, increased AST, androgenic alopecia, hyperhidrosis, alopecia, dermatitis, anxiety, mood disorders, insomnia, depression, contusion, bone contusion, concussion, bone fracture, hand fracture, laceration, palpitations, dry eye, glaucoma, cataract, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, hepatic steatosis, cholelithiasis, hearing loss, erectile dysfunction, goiter, hypertension, benign prostatic hyperplasia, pruritus
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, it is recommended to store the medication at room temperature, between 1 degree and 30 degrees Celsius, avoiding extremes of heat or cold.
Round film-coated tablet that is bright red with both sides convex and has sharp edges.
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLinagliptin 5mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Linagliptin 5mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.